Relapsed refractory multiple myeloma (rrmm) Clinical Trials

Delta Trials indexes 2 clinical trials for Relapsed refractory multiple myeloma (rrmm) in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 60 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.